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In the preparation of the above Perspective, the arrows in Figure 1 indicating the changes in serum insulin were incorrectly oriented.
We provide the correct figure here (Figure 1), showing that serum insulin is elevated with insulin resistance (red) and decreased with
increased sensitivity (green). This error does not affect the original figure legend. We regret our error and apologize for any inconve-
nience it may have caused.Figure 1. Proposed Model for McGarry’s Lipogenic Vicious Cycle, and Its Reversal
In the red, counterclockwise cycle, insulin resistance generates a self-reinforcing negative regulatory loop in which elevated insulin levels increase SREBP-1c
expression and steatosis. This further decreases insulin sensitivity and increases in serum insulin levels to continue the negative cycle. Several NRs, including ERa
CAR, LRH-1 TRb, and FXR/SHP, act to decrease SREBP-1c expression, lowering steatosis and setting up a positive, antilipogenic cycle to improved insulin
sensitivity.Elevated Hypothalamic TCPTP in Obesity
Contributes to Cellular Leptin Resistance
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